| Literature DB >> 33179570 |
Ying Hua1,2, Xiangning Bai3,4, Ji Zhang5, Cecilia Jernberg6, Milan Chromek7, Sverker Hansson8,9, Anne Frykman8,9, Xi Yang4, Yanwen Xiong4, Chengsong Wan1, Andreas Matussek2,10,11,12,13.
Abstract
Shiga toxin (Stx)-producing Escherichia coli (STEC) can cause a wide range of symptoms from asymptomatic carriage, mild diarrhea to bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Intimin, encoded by the eae gene, also plays a critical role in STEC pathogenesis. Herein, we investigated the prevalence and genetic diversity of eae among clinical STEC isolates from patients with diarrhea, BD, HUS as well as from asymptomatic STEC-positive individuals in Sweden with whole-genome sequencing. We found that 173 out of 239 (72.4%) of clinical STEC strains were eae positive. Six eae subtypes (ϵ1, γ1, β3, θ, ζ and ρ) were identified eae and its subtype γ1 were significantly overrepresented in O157:H7 strains isolated from BD and HUS patients. ϵ1 was associated with O121:H19 and O103:H2 strains, and β3 to O26:H11 strains. The combination of eae subtype γ1 and stx subtype (stx 2 or stx 1+stx 2) is more likely to cause severe disease, suggesting the possibility of using eae genotypes in risk assessment of STEC infection. In summary, this study demonstrated a high prevalence of eae in clinical STEC strains and considerable genetic diversity of eae in STEC strains in Sweden from 1994 through 2018, and revealed association between eae subtypes and disease severity.Entities:
Keywords: eae gene; Shiga toxin-producing Escherichia coli ; clinical significance; gene diversity; hemolytic uremic syndrome; intimin
Year: 2020 PMID: 33179570 PMCID: PMC7733975 DOI: 10.1080/22221751.2020.1850182
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163
Prevalence of eae gene in 239 STEC strains isolated from STEC-positive individuals.
| No. (%) | No. (%) | No. (%) | No. (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HUS ( | Non-HUS ( | BD ( | NBS ( | O157:H7 ( | Non-O157 ( | Adult ( | Child ( | |||||
| Positive | 56 (93.33) | 117 (65.36) | <0.0001* | 44 (86.27) | 73 (57.03) | <0.001* | 65 (100.00) | 108 (62.07) | <0.0001* | 44 (55.00) | 76 (73.08) | 0.011* |
| Negative | 4 (6.67) | 62 (34.64) | 7 (13.73) | 55 (42.97) | 0 (0.00) | 66 (37.93) | 36 (45.00) | 28 (26.92) | ||||
HUS: hemolytic uremic syndrome; BD: bloody diarrhea; NBS: non-bloody stool.
The association was analyzed between eae gene and clinical symptoms (HUS and non-HUS; BD and NBS), serotypes (O157 and Non-O157), age groups (Adult: ≥10 years; Child: <10 years), duration of bacterial shedding (Long: >24 days; Short: ≤24 days), only differences showing statistical significance were shown.
* Statistically significant difference.
Figure 1.Phylogenetic relationships of 29 different eae sequences identified in this study and 30 eae subtypes reference sequences based on Neighbor-Joining method. The corresponding eae subtype (number of strains), strain name, serotype (number of strains), and stx subtype (number of strains) are shown. The eae subtypes/genotypes in this study are indicated in bold and different colors. Scale bar indicates genetic distance.
Association between eae subtypes and clinical symptoms or bacterial variables.
| eae subtype | Symptoms | Symptoms | Serotypes | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. strains | HUS (n=56) | Non-HUS (n=117) | BD (n=44) | NBS (n=73) | O157:H7 (n=65) | non-O157 (n=108) | ||||||||||
| pos | prevalence | pos | prevalence | pos | prevalence | pos | prevalence | pos | prevalence | pos | prevalence | |||||
| ϵ1 | 53 | 14 | 25.00% | 39 | 33.33% | 0.27 | 13 | 29.55% | 26 | 35.62% | 0.5 | 4 | 6.15% | 49 | 45.37% | <0.001* |
| γ1 | 68 | 33 | 58.93% | 35 | 29.91% | <0.001* | 19 | 43.18% | 16 | 21.92% | 0.01* | 60 | 92.31% | 8 | 7.41% | <0.001* |
| β3 | 43 | 5 | 8.93% | 38 | 32.48% | <0.001* | 11 | 25.00% | 27 | 36.99% | 0.18 | 0 | 0.00% | 43 | 39.81% | <0.001* |
| θ | 6 | 3 | 5.36% | 3 | 2.56% | 0.35 | 1 | 2.27% | 2 | 2.74% | 0.88 | 1 | 1.54% | 5 | 4.63% | 0.28 |
| ζ3 | 2 | 1 | 1.79% | 1 | 0.85% | 0.59 | 0 | 0.00% | 1 | 1.37% | 0.44 | 0 | 0.00% | 2 | 1.85% | 0.27 |
| ρ | 1 | 0 | 0.00% | 1 | 0.85% | 0.49 | 0 | 0.00% | 1 | 1.37% | 0.44 | 0 | 0.00% | 1 | 0.93% | 0.44 |
HUS: hemolytic uremic syndrome; BD: bloody diarrhea; NBS: non-bloody stool; pos: number of positive strains.
The association was analyzed between eae subtype and clinical symptoms (HUS and non-HUS; BD and NBS), age groups, serotypes, as well as duration of bacterial shedding, only variables with differences showing statistical significance were shown in this table.
* Statistically significant difference.
Association between presence of stx + eae and clinical symptoms.
| No. (%) | No. (%) | |||||
|---|---|---|---|---|---|---|
| HUS ( | non-HUS ( | BD ( | NBS ( | |||
| 3 (5.36) | 58 (49.57) | <0.0001* | 14 (31.82) | 44 (60.27) | 0.003* | |
| 51 (91.07) | 49 (41.88) | <0.0001* | 23 (52.27) | 26 (35.62) | 0.08 | |
| 2 (3.57) | 10 (8.55) | 0.23 | 7 (15.91) | 3 (4.11) | 0.04* | |
* Statistically significant difference.
Figure 2.Minimum spanning tree of 22 STs from this study compared with 18 STs from other sources. Each circle represents a ST, with the pie divided proportionally to the number of isolates in that ST from different eae subtypes (A) or different sources (B).